EMS to acquire a 20% stake in Hypera for $678m.

EMS, a pharmaceutical company, offered to acquire a 20% stake in Hypera, a drug manufacturer in Brazil, for $678m. The leadership of both Hypera and EMS agrees that the industrial combination is undeniably beneficial, as it would solidify their position as market leaders with a 17% market share.